{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:19:51Z","timestamp":1768702791751,"version":"3.49.0"},"reference-count":42,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although psychosocial distress has been evaluated well in cancer entities like breast or prostate cancer, its impact on melanoma patients still needs to be characterized. The objectives of this study were to (i) evaluate psychosocial distress in melanoma patients using an expert rating instrument [basic documentation for psycho\u2010oncology short version (<jats:styled-content style=\"fixed-case\">PO<\/jats:styled-content>\u2010Bado <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>)]; (ii) determine associated demographic and clinical variables; and (iii) assess the acceptance of using <jats:styled-content style=\"fixed-case\">PO<\/jats:styled-content>\u2010Bado <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> as a routine procedure in a skin cancer unit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross\u2010sectional group of 696 melanoma patients was recruited. During the routine contact, doctors assessed the patients subjective distress using <jats:styled-content style=\"fixed-case\">PO<\/jats:styled-content>\u2010Bado <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>. Sociodemographic data, tumour data, treatment and the course of the disease were extracted from the patients' charts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">PO<\/jats:styled-content>\u2010Bado <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> was completed in 688 of 696 (99%) participating patients, revealing a high acceptance. In 51 (7%) patients, the <jats:styled-content style=\"fixed-case\">PO<\/jats:styled-content>\u2010Bado <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> cut\u2010off score indicated the potential need of psychosocial support. Patients with previous or ongoing radiotherapy, a history of major surgery due to organ metastases, younger age and shorter time since diagnosis were considered significantly more distressed than patients without these criteria. Patients were most distressed by suffering from anxiety\/worries and\/or tensions. In younger patients emotional variables and other problems like social or family problems were deemed more relevant while functional limitations in daily living were reasons for higher distress in older patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">PO<\/jats:styled-content>\u2010Bado <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> is a useful, well\u2010accepted, practical and economic screening tool to identify distressed melanoma patients. Although most melanoma patients seem to cope well with their disease, special attention should be given to young patients in the first years after initial diagnosis and to patients with advanced disease, radiotherapy and major surgery due to their disease. Combination of expert rating tools with self\u2010report screening instruments could further characterize the specific sources of distress to optimize psychosocial support.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.12361","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T06:59:04Z","timestamp":1391237944000},"page":"1676-1684","source":"Crossref","is-referenced-by-count":10,"title":["Characterizing psychosocial distress in melanoma patients using the expert rating instrument <scp>PO<\/scp>\u2010Bado <scp>SF<\/scp>"],"prefix":"10.1111","volume":"28","author":[{"given":"C.","family":"Loquai","sequence":"first","affiliation":[{"name":"Department of Dermatology University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Scheurich","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Syring","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Schmidtmann","sequence":"additional","affiliation":[{"name":"Institute of Medical Biostatistics Epidemiology and Informatics University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"M\u00fcller\u2010Brenne","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Werner","sequence":"additional","affiliation":[{"name":"Tumor Center Rhineland\u2010Palatinate Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grabbe","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Beutel","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy University of Mainz Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1873"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3698"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0059"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp336"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.5509"},{"key":"e_1_2_6_8_1","first-page":"31","article-title":"Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome","volume":"11","author":"Kennard BD","year":"2004","journal-title":"J Clin Psychol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015728825642"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(00)00080-5"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.549"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(02)00088-9"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.166"},{"key":"e_1_2_6_14_1","unstructured":"National Comprehensive Cancer Network.NCCN Distress Management Clinical Practice Guidelines in Oncology 2008. Available at:http:\/\/www.nccn.org(last accessed: 8 December 2013)."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"e_1_2_6_17_1","volume-title":"The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual","author":"Derogatis LR","year":"1993"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-10028"},{"key":"e_1_2_6_19_1","volume-title":"The EORTC QLQ\u2010C30 Scoring Manual (3rd Edition)","author":"Fayers PM","year":"2001"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1765"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(81)90058-8"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604420"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2008.01.003"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000162287"},{"key":"e_1_2_6_26_1","unstructured":"KellerM MusselM.PO\u2010Bado Work Group Heidelberg. PO\u2010Bado Manual. 2nd revised version 2004. Available at:http:\/\/www.po-bado.med.tu-muenchen.de(last accessed: 8 December 2013)."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1614.2000.00817.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601887"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0122"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-95"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324784"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23622"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq455"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-002-0154-x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-200603002-00011"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2007.0011"},{"key":"e_1_2_6_37_1","first-page":"258","article-title":"Psychosocial burden and subjective experience of melanoma patients in the ambulant follow\u2010up","volume":"53","author":"Blum A","year":"2003","journal-title":"Psychother Psychosom Med Psychol"},{"key":"e_1_2_6_38_1","first-page":"29","article-title":"Safety of pegylated interferon\u2010alpha\u20102a in adjuvant therapy of intermediate and high\u2010risk melanomas","volume":"18","author":"Loquai C","year":"2008","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e31821b7a4b"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00191-4"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004356-200403000-00004"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.10.001"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066800"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12361","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12361","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.12361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:45:00Z","timestamp":1695570300000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.12361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1111\/jdv.12361"],"URL":"https:\/\/doi.org\/10.1111\/jdv.12361","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}